Loading chat...

IL SB3924

Bill

Status

Introduced

1/21/2022

Primary Sponsor

Cristina Castro

Click for details

Origin

Senate

102nd General Assembly

AI Summary

SB3924 Summary

  • Creates new Section 356z.26a of the Illinois Insurance Code effective January 1, 2023, establishing requirements for clinician-administered drugs covered by health benefit plans and pharmacy benefit managers.

  • Prohibits health benefit plans from requiring enrollees to obtain clinician-administered drugs from plan-selected pharmacies, steering enrollees to specific pharmacies, requiring home infusion pharmacies, or including site of service in prior approval criteria.

  • Prohibits plans from conditioning, denying, or limiting benefits based on whether drugs are obtained from non-plan-selected providers or pharmacies, and prohibits higher cost-sharing for non-plan providers.

  • Requires clinician-administered drugs to comply with federal Drug Supply Chain Security Act standards for supply chain security and chain of distribution.

  • Applies requirements to state employee health plans, county self-insured plans, municipal self-insured plans, school district plans, health maintenance organizations, and voluntary health services plans.

Legislative Description

INS-CLINICIAN ADMINISTER DRUG

Last Action

Rule 3-9(a) / Re-referred to Assignments

2/18/2022

Committee Referrals

Assignments2/18/2022
Insurance2/1/2022
Assignments1/21/2022

Full Bill Text

No bill text available